142 related articles for article (PubMed ID: 36001384)
1. Nodal downstaging to ypN0 after neoadjuvant chemotherapy positively impacts on survival of cT4N+ GC/GEJ patients.
Wu L; Xing Z; Huang M; Yu H; Qin Y; Jin Q; Zhou Z; Chen J
J Surg Oncol; 2022 Dec; 126(8):1403-1412. PubMed ID: 36001384
[TBL] [Abstract][Full Text] [Related]
2. Nodal Downstaging of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy: Survival Analysis if ypN0 Is Achieved.
Tang H; Tan L; Wang H; Shen Y; Yin J
J Gastrointest Surg; 2020 Jul; 24(7):1469-1476. PubMed ID: 31346888
[TBL] [Abstract][Full Text] [Related]
3. Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved.
Ikoma N; Estrella JS; Hofstetter W; Das P; Minsky BD; Ajani JA; Fournier KF; Mansfield P; Badgwell BD
Ann Surg Oncol; 2018 Jul; 25(7):2012-2017. PubMed ID: 29748883
[TBL] [Abstract][Full Text] [Related]
4. Total Lymph Node Yield Is Associated with Prolonged Survival after Neoadjuvant Chemotherapy in ypN0 Gastric Cancer Patients.
Li W; Shao X; Ma F; Wang B; Xue L; Hu H; Kang W; Xiong J; Tian Y
Oncol Res Treat; 2023; 46(7-8):287-295. PubMed ID: 37302386
[TBL] [Abstract][Full Text] [Related]
5. Tumor regression grade combined with post-therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma.
Yin H; Yao Q; Xie Y; Niu D; Jiang W; Cao H; Feng X; Li Y; Li Y; Zhang X; Shen L; Chen Y
Cancer Med; 2023 Oct; 12(19):19633-19643. PubMed ID: 37749981
[TBL] [Abstract][Full Text] [Related]
6. ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer.
Zanoni A; Verlato G; Giacopuzzi S; Motton M; Casella F; Weindelmayer J; Ambrosi E; Di Leo A; Vassiliadis A; Ricci F; Rice TW; de Manzoni G
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):998-1004. PubMed ID: 27480358
[TBL] [Abstract][Full Text] [Related]
7. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
8. Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer: a Dutch population-based study.
de Wild SR; Koppert LB; de Munck L; Vrancken Peeters MTFD; Siesling S; Smidt ML; Simons JM
Breast Cancer Res Treat; 2024 Apr; 204(2):277-288. PubMed ID: 38133707
[TBL] [Abstract][Full Text] [Related]
9. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Therapy Regimen Influences the Incidence and Implication of Nodal Downstaging in Patients with Gastric Cancer.
Stark AP; Blum MM; Chiang YJ; Das P; Minsky BD; Estrella JS; Ajani JA; Badgwell BD; Mansfield P; Ikoma N
J Gastric Cancer; 2020 Sep; 20(3):313-327. PubMed ID: 33024587
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis.
Hagens E; Tukanova K; Jamel S; van Berge Henegouwen M; Hanna GB; Gisbertz S; Markar SR
Dis Esophagus; 2022 Jan; 35(1):. PubMed ID: 33893494
[TBL] [Abstract][Full Text] [Related]
12. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.
Lagarde SM; Phillips AW; Navidi M; Disep B; Griffin SM
Dis Esophagus; 2017 Dec; 30(12):1-7. PubMed ID: 28881884
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pathological nodal burden after neoadjuvant chemotherapy in initially cN0-1 breast cancer patients: a dual-center, 10-year survival analysis.
Maimaitiaili A; Fan Z; Zhang J; Wang Y; Shi B; Zheng J; Li G; Zhao Y; Pu S; He J; Qu F; Zhang H
Ther Adv Med Oncol; 2024; 16():17588359241248318. PubMed ID: 38716480
[TBL] [Abstract][Full Text] [Related]
15. Importance of Lymph Node Response After Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
Depypere L; De Hertogh G; Moons J; Provoost AL; Lerut T; Sagaert X; Coosemans W; Van Veer H; Nafteux P
Ann Thorac Surg; 2021 Dec; 112(6):1847-1854. PubMed ID: 33352178
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of pathological node status after neoadjuvant radiotherapy for rectal cancer.
Duchalais E; Glyn Mullaney T; Spears GM; Kelley SR; Mathis K; Harmsen WS; Larson DW
Br J Surg; 2018 Oct; 105(11):1501-1509. PubMed ID: 29663352
[TBL] [Abstract][Full Text] [Related]
17. Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.
Fujitani K; Nakamura K; Mizusawa J; Kuwata T; Shimoda T; Katayama H; Kushima R; Taniguchi H; Yoshikawa T; Boku N; Terashima M; Fukuda H; Sano T; Sasako M;
Gastric Cancer; 2021 Jan; 24(1):197-204. PubMed ID: 32572792
[TBL] [Abstract][Full Text] [Related]
18. External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer.
Brinkmann S; Noordman BJ; Hölscher AH; Biermann K; van Klaveren D; Bollschweiler E; Pütz K; van Lanschot JJB; Drebber U
Ann Surg Oncol; 2020 Apr; 27(4):1250-1258. PubMed ID: 31691114
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy.
Agarwal R; Philip A; Pavithran K; Rajanbabu A; Goel G; Vijaykumar DK
Indian J Cancer; 2019; 56(3):228-235. PubMed ID: 31389386
[TBL] [Abstract][Full Text] [Related]
20. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
